Irfen

Medically reviewed

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Irfen

What is Irfen?

Irfen is a medicinal product that belongs to a group of drugs known as non-steroidal anti-inflammatory drugs (NSAIDs). These medications are utilized to manage symptoms by influencing the body's chemical signaling pathways associated with inflammation and pain.

Composition and Mechanism

The active ingredient in Irfen is ibuprofen. It works by inhibiting enzymes known as cyclooxygenases (COX-1 and COX-2). These enzymes play a central role in the production of prostaglandins, which are lipid compounds produced at sites of tissue damage or infection. By reducing the concentration of prostaglandins in the body, the medication helps to decrease the sensations of pain and the physical signs of inflammation.

Therapeutic Properties

Irfen possesses three primary therapeutic properties:

Analgesic: It helps to alleviate various types of pain.
Anti-inflammatory: It reduces swelling, redness, and heat associated with inflammatory processes.
Antipyretic: It aids in the reduction of elevated body temperature (fever).

Common Applications

Due to its multifaceted mechanism of action, Irfen is frequently used in clinical practice for the symptomatic treatment of several conditions, including:

Rheumatic diseases and joint disorders.
Muscle strains, sprains, and other soft tissue injuries.
Pain following surgical or dental procedures.
Headaches and migraines.
Menstrual discomfort.
Fever associated with common colds or influenza.

What side effects are possible with Irfen?

Possible Side Effects and Safety Information: Irfen

Irfen, which contains the active ingredient ibuprofen, is generally well-tolerated when used as directed. However, like all medications, it can cause side effects. The risk and severity of side effects often increase with higher doses and prolonged treatment duration.

Common Side Effects

These side effects are typically mild and often resolve without medical intervention. They may include:

Gastrointestinal issues: Nausea, vomiting, indigestion (dyspepsia), diarrhea, or constipation.
Headache.
Dizziness or lightheadedness.
Skin rash.

Serious Side Effects

Less common but more serious side effects require immediate medical attention. Stop taking Irfen and seek emergency care if you experience:

System	Possible Serious Side Effect
Cardiovascular	Signs of a heart attack or stroke (e.g., chest pain, sudden weakness on one side, shortness of breath). Ibuprofen may increase the risk of these events, especially at high doses or in people with existing heart disease.
Gastrointestinal	Severe stomach pain, black or tarry stools, or vomit that looks like coffee grounds (signs of serious stomach bleeding or ulceration).
Allergic Reaction	Swelling of the face, throat, or tongue; difficulty breathing; or severe skin reactions (e.g., blistering or peeling).
Kidney/Liver	Significant decrease in urination, unexplained weight gain, or jaundice (yellowing of the skin or eyes), which may indicate kidney or liver problems.

Important Safety Information

Irfen should be used with caution in individuals with a history of gastrointestinal bleeding, heart disease, high blood pressure, or kidney/liver impairment. It should not be taken during the last trimester of pregnancy.

Overdose and Emergency Response

Irfen Overdose and When to Seek Help

The official regulatory documentation for Irfen (Ibuprofen) overdose details specific manifestations and mandatory emergency actions. The most frequently documented symptoms primarily involve gastrointestinal effects such as nausea, vomiting, and epigastric pain, alongside central nervous system (CNS) effects including severe headache, dizziness, confusion, unsteadiness, and tinnitus.

More severe and potentially life-threatening outcomes officially reported include convulsions (seizures), decreased level of consciousness (coma), low blood pressure (shock), acute renal failure, and significant gastrointestinal bleeding or perforation. The overdose profile establishes that these systemic risks necessitate urgent professional intervention.

Immediate medical management is required for any suspected overdose, and users are explicitly instructed to contact emergency services or a Poison Control Center right away, even if symptoms are not yet apparent. Hospital observation and monitoring of vital signs and serum electrolytes are required.

No specific antidote is known for Irfen. Treatment is symptomatic and supportive, and interventions like activated charcoal or gastric lavage may be indicated based on clinical assessment. Special considerations note that elderly patients face a greater risk of serious gastrointestinal events, and dehydrated children are at risk of acute renal impairment.

Therapeutic Uses of Irfen

What Irfen Treats: Main Uses and Benefits

Irfen is commonly used to help with symptoms related to physical discomfort and systemic imbalance. It is applied across domains where additional symptomatic support is needed, providing symptomatic relief that contributes to improved comfort during periods of heightened symptoms and temporary functional strain.

This primary use involves managing mild to moderate pain stemming from sources such as headaches, muscle aches, backaches, and toothaches, and it may assist with managing systemic imbalance by reducing fever (elevated body temperature). The medication is also relevant in contexts involving inflammatory or irritative states for conditions including osteoarthritis, certain rheumatic disorders, and discomfort from sprains and strains.

The medication is considered relevant for conditions presenting with acute episodes, recurrent manifestations, or inflammatory processes:

“It is commonly used across conditions presenting with systemic or localized discomfort, where short-term symptomatic assistance is needed.”

Furthermore, Irfen is applied in addressing symptom clusters that may become intense or disruptive, such as the recurrent manifestations of menstrual pain (dysmenorrhea). In these scenarios, the medication assists with maintaining functional stability by providing supportive relief when symptoms interfere with routine activities.

Quick Fact: Relief for Acute Discomfort
The medication is applied to address symptoms of pain, fever, and inflammation, contributing to easing the overall symptom load during periods of heightened symptoms.

Regulatory References

NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Irfen?

The eligibility for Irfen, which contains Ibuprofen, is strictly governed by regulatory status, age, and existing medical conditions.

Populations for whom use is Contraindicated

Absolute prohibition is required for:

Patients with a known history of allergic reactions (e.g., asthma, urticaria) to aspirin or other NSAIDs.
Treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Patients with active or history of recurrent peptic ulceration, GI haemorrhage, or severe organ failure (e.g., severe heart, liver, or renal failure).
Use during the third trimester of pregnancy.

Age-Related Eligibility

Pediatric Use: Generally approved for use in children aged 6 months and older for fever and pain relief. Safety and efficacy are not established below this age.
Older Adults (Geriatric): Use requires caution due to a documented increased risk of serious gastrointestinal and renal adverse events.

Restricted or Conditional Use

Use of Irfen must be approached with caution and careful consideration in patients with pre-existing conditions, including uncontrolled hypertension or congestive heart failure (NYHA Class II-III). Patients with established cardiovascular risk factors should avoid high doses (e.g., 2400 mg/day). Breastfeeding women are generally permitted to use the medicine as it poses minimal risk to the infant.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documents classify Irfen's (Ibuprofen) interaction profile into several critical domains, primarily involving pharmacodynamic reinforcement of adverse effects and pharmacokinetic alterations of co-administered medicines.

Interaction-Related Restrictions and Contraindications

Co-administration with other Non-Steroidal Anti-inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, is contraindicated due to a significantly increased risk of serious gastrointestinal ulceration and bleeding. The same restriction applies to Aspirin when used at doses exceeding 75 mg daily. Irfen is also contraindicated for the treatment of pain in the setting of coronary artery bypass graft (CABG) surgery.

Pharmacokinetic and Exposure Alterations

Irfen may reduce the renal clearance of certain medicines, a mechanism that can lead to increased plasma concentrations and potential toxicity of the co-administered drug. This exposure-modifying effect is documented for Lithium and Methotrexate. Irfen may also increase the plasma levels of Digoxin by reducing the glomerular filtration rate (GFR).

Pharmacodynamic Reinforcement of Bleeding

The medicine may enhance the effects of Anticoagulants (such as Warfarin), Corticosteroids, Anti-platelet agents, and Selective Serotonin Reuptake Inhibitors (SSRIs), increasing the documented risk of gastrointestinal hemorrhage. Furthermore, Ibuprofen may competitively interfere with the anti-platelet effect of low-dose Aspirin when administered concomitantly.

Mechanism of Action

Targeting COX Enzymes and Blocking Prostaglandin Synthesis

Irfen acts as a reversible inhibitor primarily targeting the Cyclooxygenase (COX) enzymes, specifically both the COX-1 and COX-2 forms . This molecular action prevents these enzymes from converting arachidonic acid into prostaglandins—mediators of nociception, fever, and vascular tone.

Modulating Pain Signaling and Local Tissue Response

Reduced prostaglandin synthesis results in decreased sensitization of peripheral pain receptors (nociceptors), thereby diminishing signal transmission. This mechanistic domain involves the effect on local tissue responses, as decreased prostaglandin levels limit their chemical influence on vascular permeability, resulting in decreased fluid efflux and tissue congestion.

Central Regulation of Body Temperature

A distinct mechanistic domain involves the drug's influence on the brain's thermoregulatory center in the hypothalamus. The drug inhibits prostaglandin synthesis centrally, by limiting the availability of prostaglandins that act as pyrogens (agents that elevate the hypothalamic set point) within the central nervous system. This action allows the body's internal thermostat to reset to a lower set point, resulting in a decrease in an elevated core body temperature.

Dosage and Administration Information

How Irfen is Used: Official Administration Guidelines

Irfen, which contains the active substance Ibuprofen, is administered according to established protocols. The official routes for use include oral administration (via tablets, capsules, or suspension), intravenous (IV) infusion, and topical application (such as gels).

Administration is guided by the principle of using the lowest effective dose for the shortest duration necessary to achieve the treatment goal, a directive consistent across all dosage forms. For non-prescription oral use, the standard single dose ranges from 200 mg to 400 mg, with the maximum daily dose limited to 1200 mg. Prescription regimens may range up to a total daily maximum of 3200 mg for certain inflammatory conditions, taken in divided doses, typically every 4 to 6 hours.

To promote gastrointestinal tolerance, the oral forms of Irfen are officially permitted to be taken with food or milk. The treatment duration is defined: use for acute symptoms is generally limited to 10 days for oral forms, and intravenous use, which must be administered by a qualified professional as an infusion over at least 30 minutes, is restricted to short-term treatment of usually not more than 3 days.

Specific dosage adjustments apply to certain populations. Pediatric doses are weight-based (e.g., 5 to 10 mg/kg per dose for children 6 months and older), and dose reduction is officially advised for older adults and patients with mild to moderate renal or hepatic impairment.

Recent Clinical Evidence

Irfen: Recent Clinical Evidence

Overview of Research

Clinical research on Irfen (ibuprofen) primarily consists of randomized controlled trials (RCTs) and meta-analyses. These studies evaluated the agent for its role in symptom management across a range of conditions, including various forms of acute and chronic pain, as well as fever and inflammation.

Research has explored the potential mechanisms of action, suggesting that the agent acts by inhibiting the synthesis of prostaglandins, molecules involved in inflammation and pain signaling pathways. This activity is considered central to the agent's observed effects on symptom reduction.

Key Findings

Efficacy and Dose Profile

Multiple trials have examined the efficacy profile, noting observed effects on reducing pain intensity and fever within study populations. Dose-ranging studies were conducted to compare the symptomatic effect of standard doses (e.g., 400 mg) against higher doses. The findings reported that, for certain types of acute pain, increasing the dosage beyond a specific threshold did not consistently result in a significantly greater analgesic effect.

Tolerability and Safety

Studies focused on the safety and tolerability profile have consistently reported that the most frequent adverse events were generally related to the gastrointestinal (GI) system, such as dyspepsia and abdominal discomfort. Across multiple studies comparing Irfen to placebo, the overall incidence of GI events was low at typical over-the-counter dosages. Trial inclusion criteria typically specified participants who met specific health criteria, and long-term data for individuals with certain pre-existing conditions remains limited.

Key Studies & References

Clinical Guideline: Nonsteroidal Anti-inflammatory Drugs (NSAIDs) for Acute Pain Management

Frequently Asked Questions (FAQ)

Common questions about Irfen (FAQ)

Q: Is Irfen the same kind of medicine as Advil or Motrin?

Irfen is the brand name for a medicine whose active substance is Ibuprofen. According to official sources, Advil and Motrin are also common brand names for over-the-counter products that contain the exact same active substance, Ibuprofen.

Q: Why do doctors prescribe Irfen instead of paracetamol (acetaminophen)?

Irfen is a type of medicine known as an NSAID (Non-steroidal Anti-inflammatory Drug). Official information confirms that Irfen provides significant anti-inflammatory action, in addition to relieving pain and fever, which is a key distinguishing feature compared to simple analgesics that lack this effect.

Q: How quickly does Irfen start to work for headaches?

Studies on Irfen show that the pain-relieving effect begins relatively soon after a dose is taken. The time it takes for the medicine to achieve its full effect may vary depending on the specific dosage form, such as a liquid versus a standard tablet.

Q: How long does the effect of Irfen usually last?

The administration guidelines found in regulatory documents suggest taking Irfen every 4 to 6 hours as needed for symptoms. This frequency is generally consistent with the expected duration of symptomatic relief provided by the medicine.

Q: Do you have to eat food when you take Irfen, or can you take it on an empty stomach?

Oral forms of Irfen are officially permitted to be taken with food or milk to help promote tolerance in the stomach. Taking it with food or milk may be useful if gastrointestinal upset is a concern, as this approach is permitted to promote tolerance.

Q: Can taking Irfen make you feel sleepy or tired?

Yes, regulatory information lists feelings of drowsiness, general fatigue, and somnolence (sleepiness) as possible side effects that can occur when taking Irfen.

Q: Can children take Irfen, and what's the difference between Irfen and children's pain relievers?

Irfen (ibuprofen) is generally approved for use in children aged 6 months and older for pain and fever relief. Liquid forms are frequently used for younger children because they facilitate the weight-based dosing requirements for this population. Many children's pain relievers contain the same active ingredient, ibuprofen, but the term can also refer to products containing other active substances.

Q: Does Irfen affect the kidneys?

Yes, official safety information indicates that Irfen can affect the kidneys. Patients with existing kidney impairment should use the medicine with caution, as serious issues, such as a significant decrease in urination, are documented as a possible severe side effect. If side effects like dizziness become severe or interfere with your ability to perform daily tasks, a healthcare professional should be consulted.

Q: Does Irfen have an effect on blood thinning?

Irfen is known to affect blood-clotting. Regulatory documents state it may enhance the effects of anticoagulants (blood thinners) and increase the overall risk of bleeding. Furthermore, Irfen may interfere with the anti-platelet effect of low-dose aspirin when taken concurrently.

Q: What is the difference between immediate-release and extended-release Irfen?

Official documents describe different formulations, such as standard tablets, capsules, and suspensions, which vary in how quickly the active ingredient is released. 'Immediate-release' means the medicine acts quickly, while specialized extended-release forms are available for certain higher prescription dosages and are designed to release the ingredient slowly over time.

Q: What kind of pain is Irfen best for treating?

According to the official drug label, Irfen is specifically indicated for the temporary relief of minor aches and pains associated with a variety of common conditions. These include headache, minor pain of arthritis, backache, toothache, and menstrual cramps.

Q: What are the most common things people feel when they take Irfen?

The main intended effects are the relief of pain, fever, and/or swelling. Common things people report feeling are the listed side effects, which include mild gastrointestinal issues, such as indigestion, along with potential headache and dizziness.

Q: Is it normal to have mild dizziness after taking Irfen?

Yes, official product information lists dizziness as a common side effect of Irfen (ibuprofen).

Q: What happens if I forget to take a dose of Irfen?

If Irfen is being taken as needed, a dose may be taken when remembered. If it is nearly time for the next scheduled dose, regulatory guidance suggests skipping the missed one. In all cases, it is advised not to take a double dose to make up for the one that was missed.

Q: Is Irfen habit-forming or addictive?

Official sources confirm that Irfen (ibuprofen) is not classified as an addictive substance like opioids. However, it is important to adhere to the recommended dosing duration, as excessive use of any pain reliever may contribute to a cycle of medication-overuse headaches.

Q: What should I do if Irfen doesn't seem to be helping my pain?

The FDA Drug Facts Label advises that if symptoms do not improve, or if pain lasts for more than 10 days (or fever for more than 3 days), it is recommended to discontinue use and consult with a healthcare professional.

Q: Does Irfen work better for joint pain or muscle pain?

Regulatory indications list Irfen for the temporary relief of general minor aches and pains. This comprehensive indication includes relief for both muscular aches and the minor pain associated with arthritis (which affects the joints).

Q: Are there any dietary supplements that interact with Irfen?

Official regulatory documents caution that Irfen may interact with other substances, specifically those that affect blood clotting or increase the risk of gastrointestinal bleeding. While there is no comprehensive list of every dietary supplement, caution is advised when co-administering any such products.

Q: What is the maximum number of days I should take Irfen without talking to a healthcare professional?

For pain relief, the standard recommendation on the label is not to take Irfen for longer than 10 consecutive days without speaking to a healthcare provider. For fever, the limit is typically no longer than 3 consecutive days.

Q: Is Irfen recommended for pain relief after surgery?

Irfen is specifically listed as contraindicated (should not be used) when treating pain that occurs after coronary artery bypass graft (CABG) surgery. For pain relief following other types of surgery, usage is typically evaluated by a healthcare professional.

Q: Can Irfen mask symptoms of a more serious problem?

Yes, as a pain reliever and fever reducer, Irfen’s primary action is to reduce symptoms. This action may inadvertently mask (hide) fever or pain that could be an important sign of an underlying, more serious condition.

Q: Does Irfen affect liver function?

Yes, official safety information indicates that Irfen can affect liver function. Precautions should be taken in patients with any degree of hepatic dysfunction (liver problems), and severe hepatic failure is listed as a contraindication for use.

Q: Are there any specific times of the day when it's best to take Irfen?

Regulatory dosing guidance is based on necessity. Irfen is typically taken as needed for symptoms, and the schedule is simply based on the required frequency to maintain relief, generally every 4 to 6 hours.

Q: What is the difference in strength between liquid and tablet forms of Irfen?

The strength of oral Irfen is measured by the amount of active ingredient in milligrams (mg). The equivalent dose of liquid form and tablet form is often the same, but the liquid formulation is frequently utilized for pediatric patients to accommodate necessary weight-based dosing requirements.

Q: What are the signs of an allergic reaction to Irfen?

Regulatory documents list a serious allergic reaction as a reason to stop taking Irfen immediately. Signs may include swelling of the face, throat, or tongue, difficulty breathing or wheezing, hives, and severe blistering or peeling of the skin.

Q: Do you need a prescription to get Irfen?

Irfen (ibuprofen) is available in most regions as an over-the-counter (OTC) medicine at lower doses for self-treatment. However, it is also available as a prescription medicine at higher doses used to treat specific inflammatory conditions.

Q: What kind of studies have been done on Irfen for pain management?

The clinical efficacy of Irfen for pain management is well-supported by various official studies. These typically include research methods such as randomized controlled trials (RCTs) and systematic meta-analyses that evaluate its effectiveness and safety.

Q: Can I take Irfen if I have diabetes?

Official health information specifically advises that patients with certain pre-existing conditions, including diabetes, are generally advised to consult with a healthcare professional before use.

Q: Does Irfen interact with drugs for depression or anxiety?

Yes, regulatory documents note an interaction between Irfen and Selective Serotonin Reuptake Inhibitors (SSRIs), which are a common class of antidepressants. This combination is documented to increase the risk of gastrointestinal bleeding.

Q: Is it okay to take Irfen before a dental procedure?

Studies have investigated using ibuprofen before dental procedures specifically to help manage the anticipated pain afterward. Consultation with the dental professional is advised to determine if pre-emptive use of Irfen is suitable for the specific procedure.

Q: Why does Irfen sometimes have different brand names?

Irfen contains the active substance ibuprofen. Different pharmaceutical companies market the same active ingredient under various brand names (such as Advil or Motrin) based on the packaging and specific formulation.

Q: Can Irfen be used for period pain (menstrual cramps)?

Yes, official drug indications list Irfen (ibuprofen) for the temporary relief of a variety of aches and pains. This specifically includes pain due to menstrual cramps.

Q: Is it safe to breastfeed while taking Irfen?

According to official regulatory and clinical information, Irfen is generally permitted for use during breastfeeding. It is considered to pose minimal risk to the infant because only extremely low levels of the active substance pass into breastmilk.

Q: Is it safe to drive after taking Irfen?

Irfen can cause documented side effects such as dizziness and drowsiness. Official warnings advise that it is advised not to drive or operate machinery if you experience these effects, to ensure safety.

How should Irfen be stored and disposed of?

How to Store and Dispose of Irfen (Ibuprofen)

Irfen (Ibuprofen) must be stored and disposed of according to regulatory requirements to ensure its stability and safety.

Storage Conditions

Official labeling mandates storing the medicine at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F), with permitted excursions. It must be kept in a tightly closed container and protected from light, moisture, and freezing. A mandatory safety requirement is to store the product out of the sight and reach of children at all times.

Disposal Instructions

Unused or expired Irfen must be disposed of in accordance with local regulations. The FDA strongly recommends using a drug take-back program or mail-back envelope if available. If no take-back program exists, the medicine should be mixed with an undesirable substance, sealed in a plastic bag, and discarded in the household trash, not in wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.